SG10202101836TA - Processes for preparing phosphorodiamidate morpholino oligomers - Google Patents
Processes for preparing phosphorodiamidate morpholino oligomersInfo
- Publication number
- SG10202101836TA SG10202101836TA SG10202101836TA SG10202101836TA SG10202101836TA SG 10202101836T A SG10202101836T A SG 10202101836TA SG 10202101836T A SG10202101836T A SG 10202101836TA SG 10202101836T A SG10202101836T A SG 10202101836TA SG 10202101836T A SG10202101836T A SG 10202101836TA
- Authority
- SG
- Singapore
- Prior art keywords
- processes
- morpholino oligomers
- phosphorodiamidate morpholino
- preparing
- preparing phosphorodiamidate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/6533—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/314—Phosphoramidates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/323—Chemical structure of the sugar modified ring structure
- C12N2310/3233—Morpholino-type ring
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/51—Physical structure in polymeric form, e.g. multimers, concatemers
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662340953P | 2016-05-24 | 2016-05-24 | |
| US201662341049P | 2016-05-24 | 2016-05-24 | |
| US201662357166P | 2016-06-30 | 2016-06-30 | |
| US201662357134P | 2016-06-30 | 2016-06-30 | |
| US201762508256P | 2017-05-18 | 2017-05-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10202101836TA true SG10202101836TA (en) | 2021-03-30 |
Family
ID=60412589
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201809497RA SG11201809497RA (en) | 2016-05-24 | 2017-06-30 | Processes for preparing phosphorodiamidate morpholino oligomers |
| SG10202101836TA SG10202101836TA (en) | 2016-05-24 | 2017-06-30 | Processes for preparing phosphorodiamidate morpholino oligomers |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201809497RA SG11201809497RA (en) | 2016-05-24 | 2017-06-30 | Processes for preparing phosphorodiamidate morpholino oligomers |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230045831A1 (en) |
| EP (1) | EP3463363A4 (en) |
| AU (1) | AU2017270975B2 (en) |
| BR (1) | BR112018074340A2 (en) |
| CA (1) | CA3024456A1 (en) |
| CO (1) | CO2018013834A2 (en) |
| IL (1) | IL263044B1 (en) |
| MA (1) | MA45183A (en) |
| MX (1) | MX2018014123A (en) |
| SA (1) | SA518400467B1 (en) |
| SG (2) | SG11201809497RA (en) |
| WO (1) | WO2017205880A1 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI541024B (en) | 2010-09-01 | 2016-07-11 | 日本新藥股份有限公司 | Antisense nucleic acid |
| AU2017269355B2 (en) | 2016-05-24 | 2021-04-15 | Sarepta Therapeutics, Inc. | Processes for preparing oligomers |
| MA45362A (en) | 2016-05-24 | 2019-04-10 | Sarepta Therapeutics Inc | PROCESSES FOR THE PREPARATION OF MORPHOLINO OLIGOMERS OF PHOSPHORODIAMIDATE |
| WO2017205513A1 (en) | 2016-05-24 | 2017-11-30 | Sarepta Therapeutics, Inc. | Processes for preparing phosphorodiamidate morpholino oligomers |
| US11472824B2 (en) | 2016-05-24 | 2022-10-18 | Sarepta Therapeutics, Inc. | Processes for preparing phosphorodiamidate morpholino oligomers |
| US11603532B2 (en) | 2017-06-02 | 2023-03-14 | Wave Life Sciences Ltd. | Oligonucleotide compositions and methods of use thereof |
| CN110997692A (en) | 2017-06-02 | 2020-04-10 | 波涛生命科学有限公司 | Oligonucleotide compositions and methods of use thereof |
| WO2021025899A1 (en) | 2019-08-02 | 2021-02-11 | Sarepta Therapeutics, Inc. | Phosphorodiamidate morpholino oligomer pharmaceutical compositions |
| EP4153604A1 (en) * | 2020-05-22 | 2023-03-29 | Wave Life Sciences Ltd. | Oligonucleotide compositions and methods thereof |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5185444A (en) | 1985-03-15 | 1993-02-09 | Anti-Gene Deveopment Group | Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages |
| US5217866A (en) | 1985-03-15 | 1993-06-08 | Anti-Gene Development Group | Polynucleotide assay reagent and method |
| US5034506A (en) | 1985-03-15 | 1991-07-23 | Anti-Gene Development Group | Uncharged morpholino-based polymers having achiral intersubunit linkages |
| US5166315A (en) | 1989-12-20 | 1992-11-24 | Anti-Gene Development Group | Sequence-specific binding polymers for duplex nucleic acids |
| EP0215942B1 (en) | 1985-03-15 | 1995-07-12 | Antivirals Inc. | Polynucleotide assay reagent and method |
| US5506337A (en) | 1985-03-15 | 1996-04-09 | Antivirals Inc. | Morpholino-subunit combinatorial library and method |
| US5521063A (en) | 1985-03-15 | 1996-05-28 | Antivirals Inc. | Polynucleotide reagent containing chiral subunits and methods of use |
| CA1339987C (en) | 1988-09-01 | 1998-08-04 | Robert Bruce Merrifield | Peptide synthesis method and solid support for use in the method |
| US7759513B2 (en) * | 2003-02-21 | 2010-07-20 | Nigu Chemie Gmbh | Photolabile protective groups for improved processes to prepare oligonucleotide arrays |
| US8067571B2 (en) | 2005-07-13 | 2011-11-29 | Avi Biopharma, Inc. | Antibacterial antisense oligonucleotide and method |
| US9371348B2 (en) * | 2006-11-27 | 2016-06-21 | The Trustees Of The University Of Pennsylvania | Photocleavable oligonucleotide and uses thereof |
| US8299206B2 (en) | 2007-11-15 | 2012-10-30 | Avi Biopharma, Inc. | Method of synthesis of morpholino oligomers |
| US8076476B2 (en) | 2007-11-15 | 2011-12-13 | Avi Biopharma, Inc. | Synthesis of morpholino oligomers using doubly protected guanine morpholino subunits |
| CA2704261C (en) | 2007-11-15 | 2015-05-26 | Avi Biopharma, Inc. | Method of synthesis of morpholino oligomers |
| KR102182663B1 (en) * | 2010-05-28 | 2020-11-25 | 사렙타 쎄러퓨틱스, 인코퍼레이티드 | Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups |
| ES2607603T3 (en) | 2010-09-30 | 2017-04-03 | Nippon Shinyaku Co., Ltd. | Morpholino nucleic acid derivative |
| SG11201400135SA (en) * | 2011-08-23 | 2014-03-28 | Univ Mcgill | Ionic tags for synthesis of oligoribonucleotides |
| WO2013074834A1 (en) * | 2011-11-18 | 2013-05-23 | Sarepta Therapeutics, Inc. | Functionally-modified oligonucleotides and subunits thereof |
| US9944926B2 (en) * | 2011-11-30 | 2018-04-17 | Sarepta Therapeutics, Inc. | Induced exon inclusion in spinal muscle atrophy |
| US9670529B2 (en) * | 2012-02-28 | 2017-06-06 | Population Genetics Technologies Ltd. | Method for attaching a counter sequence to a nucleic acid sample |
| HUE042218T2 (en) | 2013-03-14 | 2019-06-28 | Sarepta Therapeutics Inc | Exon skipping compositions for treating muscular dystrophy |
-
2017
- 2017-06-30 EP EP17803761.0A patent/EP3463363A4/en active Pending
- 2017-06-30 AU AU2017270975A patent/AU2017270975B2/en active Active
- 2017-06-30 IL IL263044A patent/IL263044B1/en unknown
- 2017-06-30 MA MA045183A patent/MA45183A/en unknown
- 2017-06-30 MX MX2018014123A patent/MX2018014123A/en unknown
- 2017-06-30 SG SG11201809497RA patent/SG11201809497RA/en unknown
- 2017-06-30 CA CA3024456A patent/CA3024456A1/en active Pending
- 2017-06-30 SG SG10202101836TA patent/SG10202101836TA/en unknown
- 2017-06-30 WO PCT/US2017/040318 patent/WO2017205880A1/en unknown
- 2017-06-30 BR BR112018074340-2A patent/BR112018074340A2/en unknown
-
2018
- 2018-11-20 SA SA518400467A patent/SA518400467B1/en unknown
- 2018-12-19 CO CONC2018/0013834A patent/CO2018013834A2/en unknown
-
2022
- 2022-06-15 US US17/841,185 patent/US20230045831A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL263044B1 (en) | 2024-02-01 |
| EP3463363A4 (en) | 2020-02-19 |
| BR112018074340A2 (en) | 2019-03-06 |
| MA45183A (en) | 2019-04-10 |
| CO2018013834A2 (en) | 2019-01-18 |
| EP3463363A1 (en) | 2019-04-10 |
| US20230045831A1 (en) | 2023-02-16 |
| CA3024456A1 (en) | 2017-11-30 |
| SA518400467B1 (en) | 2023-03-12 |
| AU2017270975B2 (en) | 2021-04-15 |
| AU2017270975A1 (en) | 2019-01-17 |
| IL263044A (en) | 2018-12-31 |
| SG11201809497RA (en) | 2018-12-28 |
| MX2018014123A (en) | 2019-04-29 |
| WO2017205880A1 (en) | 2017-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL263033A (en) | Processes for preparing phosphorodiamidate morpholino oligomers | |
| IL263044A (en) | Processes for preparing phosphorodiamidate morpholino oligomers | |
| ZA201708142B (en) | Process for preparing 4-amino-pyridazines | |
| HUE059158T2 (en) | Process for preparing pridopidine | |
| IL263149A (en) | Processes for preparing oligomers | |
| IL274439A (en) | Process for preparing tapinarof | |
| IL252912A0 (en) | Processes for preparing oxathiazin-like compounds | |
| IL263052A (en) | Processes for preparing phosphorodiamidate morpholino oligomers | |
| HK1247097A1 (en) | Processes for preparing fluoroketolides | |
| IL253877B (en) | Process for preparing 3-chloro-2-vinylphenylsulfonates | |
| HUE053818T2 (en) | Process for preparing hmf | |
| EP3463389A4 (en) | Processes for preparing phosphorodiamidate morpholino oligomers | |
| IL272114A (en) | Process for preparing phosphorus-containing alpha-aminonitriles | |
| ZA201908452B (en) | Improved process for preparing imetelstat | |
| ZA201903463B (en) | Method for preparing hexadecahydropyrene | |
| PT3224226T (en) | Process for preparing ethene | |
| ZA201807441B (en) | Process for preparing oxathiazin-like compounds | |
| IL253830A0 (en) | Process for preparing piperidine-4-carbothioamide hydrochloride |